This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
PHILADELPHIA & SECAUCUS, N.J.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing...
Company to be able to perform approximately 30,000 tests a week by the end of July, supplementing public health response Physicians can order the novel Quest Diagnostics lab test beginning today...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today released its 2021 Corporate Responsibility Report. The report provides information regarding...
Qualified uninsured individuals now have access to the company's COVID-19 molecular diagnostic testing at approximately 1,200 Quest Diagnostics patient service centers SECAUCUS, N.J., July 7, 2022...
Nationally representative study of more than 5 million pregnant people finds those with Medicaid less likely to be screened than those with commercial insurance, demonstrating disparities in...
ConferMED, one of the nation's leading eConsult companies, has been awarded a $2.3M grant from the Quest Diagnostics Foundation. The grant will enable ConferMED to enhance its eConsults platform...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced Cecilia McKenney, Senior Vice President and Chief Human Resources Officer (CHRO),...
"2022 Health at Work" report from Quest Diagnostics reveals the attitudes and expectations of HR executive decision makers (HREs) and employees about the changing world of work, employee health...
First quarter revenues of $2.61 billion, down 4.0% from 2021 First quarter reported diluted earnings per share ("EPS") of $2.92, down 15.6% from 2021; and adjusted diluted EPS of $3.22, down 14.4%...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has made several organizational changes and leadership appointments of seasoned...